One Thousand Days Transformed - The Campaign for Cedarville

Jeff Huston

Jeff Huston, PharmD

Associate Professor of Pharmacy Practice


Dr. Jeff Huston practiced community pharmacy for 11 years. He then accepted a position as Clinical Assistant Professor with The Ohio State University College of Pharmacy teaching in the professional practice laboratory series of courses. In December 2002, he added working with The Ohio State University College of Medicine Division of Pharmacology, ultimately serving as Lead Pharmacist for the clinical trials unit. Serving the underserved with medical care has been a major theme of career. He has led 25 medical missions trips to Honduras in coordination with World Gospel Mission, where student-pharmacists provided quality healthcare to the poorest residents of Choluteca, Honduras. He has served at Cedarville University since 2010, currently serving as Director of the Pharmacy Practice Laboratory and Associate Professor of Pharmacy Practice. In January 2021, he was appointed by Ohio Governor Mike DeWine as a pharmacist board member on the State Board of Pharmacy. 

Education and Credentials

  • PharmD, Shenandoah University 
  • BS in Pharmacy, Ohio Northern University
  • Registered Pharmacist, Kentucky, 2002 - present
  • Registered Pharmacist, Ohio, 1990 - present
  • Ohio Board of Pharmacy (1st four-year term expires June 2024, governor appointed board member

Scholarly Works

  • The Novel Uncompetitive NMDA Receptor Antagonist Esmethadone (REL-1017) Has No Meaningful Abuse Potential in Recreational Drug Users. Paolo Manfredi, Megan Shram, Jack Henningfield, Glen Apseloff, Charles Gorodetzky, Sara De Martin, Frank Vocci, Frank Sapienza, Thomas Kosten, Jeff Huston, August Buchhalter, Judy Ashworth, Ryan Lanier, Franco Folli, Andrea Mattarei, Clotilde Guidetti, Stefano Comai, Cedric O' Gorman, Sergio Traversa, Charles Inturrisi, and Marco Pappagallo. Translational Psychiatry, Nature 13, 192 (2023).
  • No meaningful opioid abuse liability of REL-1017 (esmethadone; d-methadone), a rapid-acting antidepressant in clinical development: a human abuse potential study Henningfield J, Apseloff G, Gorodetzky C, Pappagallo M, Shram M, De Martin S, Fant R, Vocci F, Sapienza F, Kosten T, Huston J, Buchhalter A, Ashworth J, Lanier R, Folli F, Traversa S, Inturrisi C, Manfredi P. American College of Neuropsychopharmacology (ACNP) 60th Annual Meeting 2021. Neuropsychopharmacol. 46, 218-368, P315 (2021).
  • Learning Beyond the Degree: Creation of a Pharmacy Continuing Professional Development (CPD) Program at a Large Health System August 2020 Laura Duvall, PharmD, BCPS; Jeff Huston, PharmD Ohio Pharmacist Association Annual Conference, Columbus Ohio
  • The Pharmacist’s Role in a Clinical Trials Unit. April 2018 Laura Duvall, PharmD, BCPS; Jeff Huston R.Ph. Ohio Pharmacists Association Annual Conference, Columbus, Ohio
  • Mission is at the core of who we are. Franz T, Thronton P, Huston J, July 2016 Hartzler M, Laswell E, and Chambers K., Christianity & Pharmacy 2016:19(1):16-18.
  • Pharmacy Services: Culturally Sensitive Medication Acquisition and Use 2014, ACPE approved CPE, Global Missions Health Conference Louisville, KY
  • The effects of faith-based values and an exercise program on 2014, Cardiovascular Risk Factors. Crommett A, Cameron G, Huston J, O’Hara K, Albury A, Thorpe G, Forsythe J. Christian Society of Kinesiology and Leisure Studies Annual Meeting, Mechanicsburg, PA

View a listing of scholarly works in the Cedarville University Digital Commons »


Traveling to foreign countries with the family (have been to 37 countries), medical missions trips to Honduras (25+ trips), boating at Lake Cumberland, beach and any water activities, any time spent with family

Why Cedarville

God is orchestrating so many amazing things for Cedarville University School of Pharmacy. I feel so very blessed to be a part of this great new adventure of training students to use their faith and God given talents to serve the health care needs of others thus opening the door to serve patients spiritual needs.